- Home
- BZFD vs ASMB Comparison
BZFD vs ASMB Comparison
Compare BZFD & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- ASMB
- Stock Information
- Founded
- BZFD 2006
- ASMB 2005
- Country
- BZFD United States
- ASMB United States
- Employees
- BZFD N/A
- ASMB N/A
- Industry
- BZFD Movies/Entertainment
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- BZFD Consumer Discretionary
- ASMB Health Care
- Exchange
- BZFD Nasdaq
- ASMB Nasdaq
- Market Cap
- BZFD 77.5M
- ASMB 84.5M
- IPO Year
- BZFD N/A
- ASMB 2010
- Fundamental
- Price
- BZFD $2.13
- ASMB $9.56
- Analyst Decision
- BZFD
- ASMB Strong Buy
- Analyst Count
- BZFD 0
- ASMB 3
- Target Price
- BZFD N/A
- ASMB $33.00
- AVG Volume (30 Days)
- BZFD 435.7K
- ASMB 27.4K
- Earning Date
- BZFD 03-13-2025
- ASMB 03-20-2025
- Dividend Yield
- BZFD N/A
- ASMB N/A
- EPS Growth
- BZFD N/A
- ASMB N/A
- EPS
- BZFD N/A
- ASMB N/A
- Revenue
- BZFD $189,887,000.00
- ASMB $28,520,000.00
- Revenue This Year
- BZFD $89.62
- ASMB N/A
- Revenue Next Year
- BZFD $4.50
- ASMB $107.23
- P/E Ratio
- BZFD N/A
- ASMB N/A
- Revenue Growth
- BZFD N/A
- ASMB 298.16
- 52 Week Low
- BZFD $1.26
- ASMB $9.56
- 52 Week High
- BZFD $5.68
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- BZFD 46.85
- ASMB 31.18
- Support Level
- BZFD $2.12
- ASMB $10.70
- Resistance Level
- BZFD $2.48
- ASMB $11.78
- Average True Range (ATR)
- BZFD 0.14
- ASMB 0.56
- MACD
- BZFD 0.03
- ASMB 0.00
- Stochastic Oscillator
- BZFD 42.11
- ASMB 0.00
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.